These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282 [TBL] [Abstract][Full Text] [Related]
44. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients. Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338 [TBL] [Abstract][Full Text] [Related]
51. Opportunistic infections complicating solid organ transplantation with alemtuzumab induction. Helfrich M; Ison MG Transpl Infect Dis; 2015 Oct; 17(5):627-36. PubMed ID: 26228653 [TBL] [Abstract][Full Text] [Related]
52. Infectious complications in HIV-infected kidney transplant recipients. Ailioaie O; Arzouk N; Valantin MA; Tourret J; Calin RO; Turinici M; Mircescu G; Barrou B Int J STD AIDS; 2018 Mar; 29(4):341-349. PubMed ID: 28862528 [TBL] [Abstract][Full Text] [Related]
53. A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: A single-center study. Majeed A; Beatty N; Iftikhar A; Mushtaq A; Fisher J; Gaynor P; Kim JC; Marquez JL; Mora FE; Georgescu A; Zangeneh T Transpl Infect Dis; 2018 Aug; 20(4):e12904. PubMed ID: 29668074 [TBL] [Abstract][Full Text] [Related]
54. Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients. Gabardi S; Catella J; Martin ST; Perrone R; Chandraker A; Magee CC; McDevitt-Potter LM Ann Pharmacother; 2011 Sep; 45(9):e48. PubMed ID: 21811001 [TBL] [Abstract][Full Text] [Related]
55. Tacrolimus: a further update of its use in the management of organ transplantation. Scott LJ; McKeage K; Keam SJ; Plosker GL Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696 [TBL] [Abstract][Full Text] [Related]
56. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
57. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population. Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584 [TBL] [Abstract][Full Text] [Related]
58. Disseminated histoplasmosis in renal transplant recipients. Davies SF; Sarosi GA; Peterson PK; Khan M; Howard RJ; Simmons RL; Najarian JS Am J Surg; 1979 May; 137(5):686-91. PubMed ID: 378009 [TBL] [Abstract][Full Text] [Related]
59. Disseminated histoplasmosis in a haemodialysis patient on immunosuppression after graft failure. Smak Gregoor PJ; van Saase JL; vd Ingh HF; Weimar W; Kramer P Nephrol Dial Transplant; 1996 Mar; 11(3):542-4. PubMed ID: 8671831 [No Abstract] [Full Text] [Related]
60. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). McKinsey DS; Gupta MR; Riddler SA; Driks MR; Smith DL; Kurtin PJ Ann Intern Med; 1989 Oct; 111(8):655-9. PubMed ID: 2802421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]